Identification of breast cancer transcortin and its inhibitory role in cell-mediated immunity View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1976-08

AUTHORS

LEONA AMARAL, SEYMOUR WERTHAMER

ABSTRACT

THE successful development and maintenance of a neoplastic malignancy is generally accepted to result from a temporary or lasting suppression of cell-mediated immune mechanisms. Many studies illustrate that whereas lymphocytes of a cancer patient are functionally sound, their participation in cell-mediated immune responses to an anti-genie neoplasm is abrogated by factors present in the plasma1. Among such factors identified are certain plasma proteins whose concentrations are markedly higher in the plasma of the cancer patient2. We have shown that the content of transcortin, the cortisol-binding protein of human plasma, is higher in patients with demonstrable cancer3, and since transcortin inhibits the response of human lymphocytes to phytohaemagglutinin4, a test generally accepted as demonstrative of active cell-mediated potential, we have attempted to study the relationship of such elevated levels of plasma transcortin to breast cancer. More... »

PAGES

589

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/262589a0

DOI

http://dx.doi.org/10.1038/262589a0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1008805244

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8726


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenofibroma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Intraductal, Noninfiltrating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytosol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gynecomastia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunity, Cellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcortin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "AMARAL", 
        "givenName": "LEONA", 
        "type": "Person"
      }, 
      {
        "familyName": "WERTHAMER", 
        "givenName": "SEYMOUR", 
        "id": "sg:person.063777024.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.063777024.27"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0304-4165(74)90226-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007977611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0304-4165(74)90226-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007977611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/acta.0.0620468", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022315791"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci108341", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026465860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0014-2964(75)90072-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036060388"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075218985", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080143234", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080339788", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080871159", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1976-08", 
    "datePublishedReg": "1976-08-01", 
    "description": "THE successful development and maintenance of a neoplastic malignancy is generally accepted to result from a temporary or lasting suppression of cell-mediated immune mechanisms. Many studies illustrate that whereas lymphocytes of a cancer patient are functionally sound, their participation in cell-mediated immune responses to an anti-genie neoplasm is abrogated by factors present in the plasma1. Among such factors identified are certain plasma proteins whose concentrations are markedly higher in the plasma of the cancer patient2. We have shown that the content of transcortin, the cortisol-binding protein of human plasma, is higher in patients with demonstrable cancer3, and since transcortin inhibits the response of human lymphocytes to phytohaemagglutinin4, a test generally accepted as demonstrative of active cell-mediated potential, we have attempted to study the relationship of such elevated levels of plasma transcortin to breast cancer.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/262589a0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018957", 
        "issn": [
          "0090-0028", 
          "1476-4687"
        ], 
        "name": "Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5569", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "262"
      }
    ], 
    "name": "Identification of breast cancer transcortin and its inhibitory role in cell-mediated immunity", 
    "pagination": "589", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "29f3d743534d3540860c2bfd316abb1dc284897fa33d3794b67d23443a69b6b4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8726"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0410462"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/262589a0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1008805244"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/262589a0", 
      "https://app.dimensions.ai/details/publication/pub.1008805244"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000362_0000000362/records_87119_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/262589a0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/262589a0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/262589a0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/262589a0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/262589a0'


 

This table displays all metadata directly associated to this object as RDF triples.

138 TRIPLES      21 PREDICATES      49 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/262589a0 schema:about N106d41350f3f4853936ab8726f365e4f
2 N1491a2a18b1f4bba9f2cff42ba55b84b
3 N4a18a61197b84778ae9f5d6c6471dcb2
4 N58272107fb4241edaaab98ae6634ed3a
5 N625bc8c5405e4d008651f54ffb946cd2
6 N80edef97f01d421fa5055a707166c86c
7 Nbe4307813acb4cad965883dc8a7ad7fa
8 Nc4a16e760def48ac9aecf9220f89c7e4
9 Nc4aa0bfb04f74cc2b2e0eab8bdd46e63
10 Ndbd49bd2902046fcad47b4b92d5cdf82
11 Necf0845296794e0f98786cef6c212c7b
12 Nf99d99ded4a1429dbd05b3d48b52e762
13 anzsrc-for:11
14 anzsrc-for:1107
15 schema:author Nd1ff88c316f84f619588cec12a4122c7
16 schema:citation https://app.dimensions.ai/details/publication/pub.1075218985
17 https://app.dimensions.ai/details/publication/pub.1080143234
18 https://app.dimensions.ai/details/publication/pub.1080339788
19 https://app.dimensions.ai/details/publication/pub.1080871159
20 https://doi.org/10.1016/0014-2964(75)90072-9
21 https://doi.org/10.1016/0304-4165(74)90226-8
22 https://doi.org/10.1172/jci108341
23 https://doi.org/10.1530/acta.0.0620468
24 schema:datePublished 1976-08
25 schema:datePublishedReg 1976-08-01
26 schema:description THE successful development and maintenance of a neoplastic malignancy is generally accepted to result from a temporary or lasting suppression of cell-mediated immune mechanisms. Many studies illustrate that whereas lymphocytes of a cancer patient are functionally sound, their participation in cell-mediated immune responses to an anti-genie neoplasm is abrogated by factors present in the plasma1. Among such factors identified are certain plasma proteins whose concentrations are markedly higher in the plasma of the cancer patient2. We have shown that the content of transcortin, the cortisol-binding protein of human plasma, is higher in patients with demonstrable cancer3, and since transcortin inhibits the response of human lymphocytes to phytohaemagglutinin4, a test generally accepted as demonstrative of active cell-mediated potential, we have attempted to study the relationship of such elevated levels of plasma transcortin to breast cancer.
27 schema:genre research_article
28 schema:inLanguage en
29 schema:isAccessibleForFree false
30 schema:isPartOf N2e3a52ac1172420ab5a71aa3a5603b52
31 N5d8a905c93fe45eca2ca1dff80a9442c
32 sg:journal.1018957
33 schema:name Identification of breast cancer transcortin and its inhibitory role in cell-mediated immunity
34 schema:pagination 589
35 schema:productId N175819c977354c669abfd6c8e342704b
36 N766b1dca810b4646890c9aed43052539
37 N9ead231ea75042e794bc9943dd1e05ea
38 Naca9f865b9db48c889910713cdff2189
39 Nb594598b215e498d86ff8a7889197970
40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008805244
41 https://doi.org/10.1038/262589a0
42 schema:sdDatePublished 2019-04-11T12:27
43 schema:sdLicense https://scigraph.springernature.com/explorer/license/
44 schema:sdPublisher N8c0b525ed2244e8aba14144b19495e41
45 schema:url https://www.nature.com/articles/262589a0
46 sgo:license sg:explorer/license/
47 sgo:sdDataset articles
48 rdf:type schema:ScholarlyArticle
49 N106d41350f3f4853936ab8726f365e4f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
50 schema:name Immunity, Cellular
51 rdf:type schema:DefinedTerm
52 N1491a2a18b1f4bba9f2cff42ba55b84b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
53 schema:name Cytosol
54 rdf:type schema:DefinedTerm
55 N175819c977354c669abfd6c8e342704b schema:name doi
56 schema:value 10.1038/262589a0
57 rdf:type schema:PropertyValue
58 N2e3a52ac1172420ab5a71aa3a5603b52 schema:volumeNumber 262
59 rdf:type schema:PublicationVolume
60 N4a18a61197b84778ae9f5d6c6471dcb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Humans
62 rdf:type schema:DefinedTerm
63 N58272107fb4241edaaab98ae6634ed3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Carcinoma
65 rdf:type schema:DefinedTerm
66 N5d8a905c93fe45eca2ca1dff80a9442c schema:issueNumber 5569
67 rdf:type schema:PublicationIssue
68 N625bc8c5405e4d008651f54ffb946cd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Breast Neoplasms
70 rdf:type schema:DefinedTerm
71 N766b1dca810b4646890c9aed43052539 schema:name pubmed_id
72 schema:value 8726
73 rdf:type schema:PropertyValue
74 N80edef97f01d421fa5055a707166c86c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Female
76 rdf:type schema:DefinedTerm
77 N8c0b525ed2244e8aba14144b19495e41 schema:name Springer Nature - SN SciGraph project
78 rdf:type schema:Organization
79 N9ead231ea75042e794bc9943dd1e05ea schema:name nlm_unique_id
80 schema:value 0410462
81 rdf:type schema:PropertyValue
82 Naca9f865b9db48c889910713cdff2189 schema:name readcube_id
83 schema:value 29f3d743534d3540860c2bfd316abb1dc284897fa33d3794b67d23443a69b6b4
84 rdf:type schema:PropertyValue
85 Nb594598b215e498d86ff8a7889197970 schema:name dimensions_id
86 schema:value pub.1008805244
87 rdf:type schema:PropertyValue
88 Nbe4307813acb4cad965883dc8a7ad7fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Transcortin
90 rdf:type schema:DefinedTerm
91 Nc4a16e760def48ac9aecf9220f89c7e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Adenofibroma
93 rdf:type schema:DefinedTerm
94 Nc4aa0bfb04f74cc2b2e0eab8bdd46e63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Carcinoma, Intraductal, Noninfiltrating
96 rdf:type schema:DefinedTerm
97 Nd1ff88c316f84f619588cec12a4122c7 rdf:first Ne0f20643b2e44acdb2d27abb3eb8bf75
98 rdf:rest Ndf35bdd8f64d43a38726df448d5f7894
99 Ndbd49bd2902046fcad47b4b92d5cdf82 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name T-Lymphocytes
101 rdf:type schema:DefinedTerm
102 Ndf35bdd8f64d43a38726df448d5f7894 rdf:first sg:person.063777024.27
103 rdf:rest rdf:nil
104 Ne0f20643b2e44acdb2d27abb3eb8bf75 schema:familyName AMARAL
105 schema:givenName LEONA
106 rdf:type schema:Person
107 Necf0845296794e0f98786cef6c212c7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Male
109 rdf:type schema:DefinedTerm
110 Nf99d99ded4a1429dbd05b3d48b52e762 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Gynecomastia
112 rdf:type schema:DefinedTerm
113 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
114 schema:name Medical and Health Sciences
115 rdf:type schema:DefinedTerm
116 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
117 schema:name Immunology
118 rdf:type schema:DefinedTerm
119 sg:journal.1018957 schema:issn 0090-0028
120 1476-4687
121 schema:name Nature
122 rdf:type schema:Periodical
123 sg:person.063777024.27 schema:familyName WERTHAMER
124 schema:givenName SEYMOUR
125 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.063777024.27
126 rdf:type schema:Person
127 https://app.dimensions.ai/details/publication/pub.1075218985 schema:CreativeWork
128 https://app.dimensions.ai/details/publication/pub.1080143234 schema:CreativeWork
129 https://app.dimensions.ai/details/publication/pub.1080339788 schema:CreativeWork
130 https://app.dimensions.ai/details/publication/pub.1080871159 schema:CreativeWork
131 https://doi.org/10.1016/0014-2964(75)90072-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036060388
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1016/0304-4165(74)90226-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007977611
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1172/jci108341 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026465860
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1530/acta.0.0620468 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022315791
138 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...